Cargando…
Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19
Non‐steroidal anti‐inflammatory drugs (NSAIDs) and other eicosanoid pathway modifiers are among the most ubiquitously used medications in the general population. Their broad anti‐inflammatory, antipyretic, and analgesic effects are applied against symptoms of respiratory infections, including SARS‐C...
Autores principales: | Sokolowska, Milena, Rovati, G Enrico, Diamant, Zuzana, Untersmayr, Eva, Schwarze, Jürgen, Lukasik, Zuzanna, Sava, Florentina, Angelina, Alba, Palomares, Oscar, Akdis, Cezmi, O'Mahony, Liam, Jesenak, Milos, Pfaar, Oliver, Torres, María José, Sanak, Marek, Dahlén, Sven‐Erik, Woszczek, Grzegorz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111413/ https://www.ncbi.nlm.nih.gov/pubmed/35174512 http://dx.doi.org/10.1111/all.15258 |
Ejemplares similares
-
AllergoOncology – the impact of allergy in oncology: EAACI position paper
por: Jensen‐Jarolim, E., et al.
Publicado: (2017) -
Research needs in allergy: an EAACI position paper, in collaboration with EFA
por: Papadopoulos, Nikolaos G, et al.
Publicado: (2012) -
The association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension
por: McNeill, Jenna N., et al.
Publicado: (2023) -
Alpine altitude climate treatment for severe and uncontrolled asthma: An EAACI position paper
por: Fieten, Karin B., et al.
Publicado: (2022) -
Eicosanoid Mediators in the Airway Inflammation of Asthmatic Patients: What is New?
por: Sanak, Marek
Publicado: (2016)